Nita Patel, MS, CRP

Director
Novavax, Inc.
Gaithersburg, Maryland, United States

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• LB746 - Safety and Immunogenicity of a Booster Dose of Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) in Adults from the PREVENT-19 Trial in the United States

  Thursday, October 20, 2022
  1:57 PM – 2:09 PM US ET